Ambeed.cn

首页 / / / / ZLDI-8

ZLDI-8 {[allProObj[0].p_purity_real_show]}

货号:A1250008

ZLDI-8是一种Notch活化/裂解酶ADAM-17的抑制剂,能够抑制Notch蛋白的裂解,并降低与细胞存活、抗凋亡及上皮-间质转化相关蛋白的表达。ZLDI-8 还作为一种竞争性且不可逆的酪氨酸磷酸酶(Lyp)抑制剂(IC50=31.6 μM,Ki=26.22 μM),对MHCC97-H细胞生长的IC50为5.32 μM。

ZLDI-8 化学结构 CAS号:667880-38-8
ZLDI-8 化学结构
CAS号:667880-38-8
ZLDI-8 3D分子结构
CAS号:667880-38-8
ZLDI-8 化学结构 CAS号:667880-38-8
ZLDI-8 3D分子结构 CAS号:667880-38-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

ZLDI-8 纯度/质量文件 产品仅供科研

货号:A1250008 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Neuron, 2025. Ambeed. [ A1440350 ]
Nature Communications, 2025, 16, 996. Ambeed. [ A111960 , A505336 ]
JACS, 2025. Ambeed. [ A349578 , A2270125 ]
PLoS Biol., 2025, 23(2): e3002961. Ambeed. [ A181909 ]
Redox Rep., 2025, 30(1): 2454887. Ambeed. [ A1155014 ]
更多 >

ZLDI-8 生物活性

描述 ZLDI-8 acts as an inhibitor of the Notch activating/cleaving enzyme ADAM-17, preventing Notch protein cleavage. It reduces the levels of proteins associated with survival, anti-apoptosis, and epithelial-mesenchymal transition (EMT). Furthermore, ZLDI-8 serves as a competitive and irreversible inhibitor of tyrosine phosphatase (Lyp), exhibiting an IC50 of 31.6 μM and a Ki of 26.22 μM. It effectively curbs the proliferation of MHCC97-H cells with an IC50 of 5.32 μM[1][2].
体内研究

ZLDI-8 treatment (0.2-2 mg/kg; intraperitoneal injection; every two days; for 20 days; nude mice) boosts the efficacy of Sorafenib in suppressing tumor growth in a nude mouse model of HCC[1].

体外研究

ZLDI-8 treatment (0.03-30 μM; 6-72 hours; MHCC97-H cells) decreases cell viability in both a time- and dose-dependent way[1].

ZLDI-8 (1-10 μM; 6-72 hours; MHCC97-H cells) markedly lowers NICD levels and its nuclear accumulation. It also diminishes the expression of pro-survival/anti-apoptosis proteins, Survivin and cIAP1/2, while enhancing the epithelial marker E-Cadherin and reducing mesenchymal markers N-Cadherin and Vimentin[1].

ZLDI-8 amplifies chemotherapy's impact on halting tumor cell proliferation, inducing apoptosis, and causing cell-cycle arrest by obstructing the Notch pathway and overcoming chemical resistance[1].

ZLDI-8 参考文献

[1]Zhang Y, et al. Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Cell Death Dis. 2018 Jul 3;9(7):743.

[2]Hou X, et al. Fast identification of novel lymphoid tyrosine phosphatase inhibitors using target-ligand interaction-based virtual screening. J Med Chem. 2014 Nov 26;57(22):9309-22.

ZLDI-8 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.31mL

0.46mL

0.23mL

11.53mL

2.31mL

1.15mL

23.07mL

4.61mL

2.31mL

ZLDI-8 技术信息

CAS号667880-38-8
分子式C24H23N3O3S
分子量 433.523
别名
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 60 mg/mL(138.4 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。